文献速递儿科影像神经MR

儿童MOGAD病灶T2信号异质性对强化的影响

The effect of T2 signal heterogeneity on gadolinium enhancement in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease: a quantitative magnetic resonance imaging study.
PubMed 文献 · Pediatr Radiol · 2026-06-15

研究发现急性强化病灶的T2异质性比值显著高于不强化病灶,随访病灶T2比值较急性期下降。Max/Min比值在病灶级(AUC 0.802)和患者级(AUC 0.837)预测强化方面均表现最佳。

要点

  • T2信号异质性增高可提示MOGAD病灶存在炎性强化活动。
  • Max/Min比值与病灶面积校正后诊断效能稳定,可作为无对比剂时的替代参考指标。
  • 随访中T2异质性比值下降可反映炎性活动消退。

核心结论

  • T2信号异质性可以提示儿童MOGAD病灶的炎性活动。
  • Max/Min比值在病灶级(AUC 0.802,95%CI 0.739-0.864)和患者级(AUC 0.837,95%CI 0.739-0.934)均能较好预测强化。

研究设计与样本

  • 回顾性研究,纳入70例儿童MOGAD患者共190个脑病灶(99个强化、91个不强化)。
  • 定量分析包括病灶面积、T2信号强度(Mean、SD、Max、Min)及与胼胝体的归一化比值。

关键影像表现/征象

  • 急性强化病灶的轴向面积更大,T2异质性比值(Max/CC、SD/CC、Max-Min/CC、Max/Min)均显著高于不强化病灶(均P<0.001)。
  • 急性强化病灶的Mean/CC比值也高于不强化病灶(P=0.001)。
  • 随访病灶面积缩小(P<0.001),T2归一化比值(Max/CC、SD/CC、Max-Min/CC、Max/Min)均较急性期下降(均P<0.001)。
  • 急性不强化病灶与随访病灶在所有定量参数上均无显著差异(均P>0.05)。

诊断标准与关键数值

  • Max/Min比值在病灶级预测强化的AUC为0.802,95%CI为0.739-0.864。
  • Max/Min比值在患者级分类中的AUC为0.837,95%CI为0.739-0.934。
  • ANCOVA显示病灶组×病灶面积对Max/CC、Max-Min/CC和Max/Min存在显著交互效应(均P<0.05)。

临床应用与阅片要点

  • 阅片时可关注T2信号的不均匀程度,信号异质性明显增高与强化活动相关。
  • 在不能使用对比剂时,Max/Min比值可作为病灶炎性活动评估的参考指标。
  • 随访中T2异质性比值下降可用于监测病灶炎性活动的消退。

局限性

  • 研究为回顾性设计,存在选择偏倚的可能。
  • 随访中位时间仅39天,长期演变趋势未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: T2-hyperintensity and gadolinium enhancement mark inflammation in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), yet the significance of T2 signal heterogeneity remains underexplored.

OBJECTIVE: To investigate the relationship between quantitative T2 signal heterogeneity metrics and lesion enhancement.

MATERIALS AND METHODS: We retrospectively reviewed 70 MOGAD pediatric patients with 190 brain lesions (99 enhanced, 91 non-enhanced). Twenty-six patients underwent follow-up magnetic resonance imaging (MRI) (median 39 days) evaluating 57 baseline-enhanced lesions. Quantitative analysis included lesion area, T2 signal intensity (mean, standard deviation [SD], maximum [Max], minimum [Min]), and normalized ratios to the corpus callosum (CC).

RESULTS: Acute enhanced lesions exhibited larger axial areas and elevated T2 heterogeneity ratios (Max/CC, SD/CC, Max-Min/CC and Max/Min, all P<0.001) and Mean/CC (P=0.001) versus non-enhanced lesions. Follow-up lesions showed smaller areas (P<0.001) and normalized T2 ratios (Max/CC, SD/CC, Max-Min/CC and Max/Min, all P<0.001) versus their acute-phase counterparts. Analysis of covariance (ANCOVA) identified significant group×lesion area interaction effects for Max/CC, Max-Min/CC, and Max/Min (all P<0.05). Acute non-enhancing lesions and follow-up lesions showed no significant differences across all quantitative parameters (all P>0.05). The Max/Min ratio demonstrated superior diagnostic performance for lesion-level enhancement prediction (area under the receiver operating characteristic curve [AUC] 0.802, 95% confidence interval [CI] 0.739-0.864) and patient-level classification (AUC 0.837, 95% CI 0.739-0.934).

CONCLUSION: T2 signal heterogeneity can suggest inflammatory activity in MOGAD. The Max/Min ratio provides a clinically applicable predictor for lesion enhancement and disease monitoring.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang, Fan, Cheng, et al. The effect of T2 signal heterogeneity on gadolinium enhancement in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease: a quantitative magnetic resonance imaging study. Pediatr Radiol. 2026. PMID: 42295378. doi:10.1007/s00247-026-06694-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。